Cryoneurolysis to treat the pain and symptoms of knee osteoarthritis: a multicenter, randomized, double-blind, sham-controlled trial.
R Radnovich, D Scott, A T Patel...
https://pubmed.ncbi.nlm.nih.gov/28336454/Actively Recruiting
Led by Montefiore Medical Center · Updated on 2026-06-17
110
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating two different treatments for chronic low back pain caused by facet joint problems. This study compares the iovera system, which uses cold to treat certain nerves in the lower back, with the standard treatment called radiofrequency ablation, which uses heat. The study aims to find out which treatment better reduces back pain and improves quality of life over about a year. It is a randomized, double-blind study sponsored by Montefiore Medical Center. Participants will be randomly assigned to receive either iovera cryoneurolysis or radiofrequency ablation targeting the medial branch nerves of the lumbar spine. The iovera treatment involves using a needle and the iovera Smart Tip to apply cold cycles to the nerves, while the radiofrequency ablation uses a needle to deliver heat lesions at specific nerve locations. Both procedures are done under fluoroscopic guidance with local anesthesia. The study includes an adaptive design with an interim analysis after about 56 participants have completed the primary outcome assessment. Participants will be monitored before and after the treatment for about 12 months, with regular assessments of pain intensity using a numeric rating scale, functional disability, patient global impression of change, and overall health. Researchers will also evaluate safety outcomes, medication use, quality of life, and participant satisfaction with pain management. The study lasts approximately 14 months for each participant, including follow-up visits to track the long-term effects of the treatments.
CONDITIONS
A Prospective Study to Evaluate the Efficacy of Iovera Lumbar Medial Branch Cryoneurolysis Versus Radiofrequency Ablation for the Treatment of Chronic Low Back Pain
K
Karina Gritsenko, MD
R
Rafi Khandaker, BA
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Montefiore Medical Center
Lead Sponsor
Pacira Pharmaceuticals, Inc
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Iovera Medial Branch Cryoneurolysis | Radiofrequency Ablation (RFA) |
|---|---|---|
| What it is | A device procedure using iovera Smart Tip technology to freeze the lumbar medial branch nerve, aiming to block pain signals from facet joints. | A common interventional technique where radiofrequency energy heats and disables the lumbar medial branch nerve to reduce pain from facet joints. |
| Role in the trial | Investigational device arm. Participants receive cryoneurolysis under fluoroscopic guidance. | Active comparator arm. Participants receive radiofrequency ablation intervention. |
| Primary use | Relieve moderate to severe chronic low back pain believed to originate from facet joint pathology. | Relieve moderate to severe chronic low back pain due to facet joint involvement, following guideline-supported criteria for RFA. |
| How it is given or performed | Cryoneurolysis is done under fluoroscopic guidance using the iovera device, which freezes the target nerve through skin and tissue layers after anesthetic injection. | RFA involves placing a radiofrequency needle at the lumbar medial branch under fluoroscopy, confirming position, injecting local anesthetic, and heating the nerve to create a lesion. |
| Evidence status | Limited published evidence exists for cryoneurolysis in lumbar facet joint pain, with a small prospective trial showing potential benefit but broader pain applications are more established. | Multiple large trials and guideline reviews support the established efficacy of RFA for facet-related chronic low back pain across diverse populations. |
| Important limitations | Published studies include small sample sizes and variable techniques for lumbar application. Long-term outcomes and comparative effectiveness versus RFA remain under investigation. | RFA is effective but may not provide permanent relief and repeat procedures may be required. Technique, patient selection, and anatomical variations influence outcome. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening visit
Duration - 1 day
Participants receive either iovera cryoneurolysis or radiofrequency ablation targeting the medial branch nerves in the lumbar spine.
1 treatment visit
Duration - 12 months
Participants are monitored with regular visits to assess pain levels, functional ability, safety, and overall health for about 12 months after treatment.
Periodic follow-up visits throughout 12 months
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
R Radnovich, D Scott, A T Patel...
https://pubmed.ncbi.nlm.nih.gov/28336454/Laxmaiah Manchikanti, Alan D Kaye, Amol Soin...
https://pubmed.ncbi.nlm.nih.gov/32503359/Vinod Dasa, Gabriel Lensing, Miles Parsons...
https://pubmed.ncbi.nlm.nih.gov/26875052/D Barnard
https://pubmed.ncbi.nlm.nih.gov/7396346/Johnathon P Shaffer, Vernon B Williams, Steven S Shin
https://pubmed.ncbi.nlm.nih.gov/35601731/J D Cassidy, L J Carroll, P Côté
https://pubmed.ncbi.nlm.nih.gov/9762743/P J Evans, J W Lloyd, C J Green
https://pubmed.ncbi.nlm.nih.gov/7326160/Romain Perolat, Adrian Kastler, Benjamin Nicot...
https://pubmed.ncbi.nlm.nih.gov/30090998/Steven P Cohen, Arun Bhaskar, Anuj Bhatia...
https://pubmed.ncbi.nlm.nih.gov/32245841/Jonathan Rubenstein, Alexandra W Harvey, Daniel Vincent...
https://pubmed.ncbi.nlm.nih.gov/33105153/Montefiore Medical Center
Lead Sponsor
Pacira Pharmaceuticals, Inc
Collaborating Sponsor